Among the most vulnerable groups there are disabled people, pensioners, pregnant women and women on maternity leave.
According to Izvestia’s preliminary information, such a situation comes from the ineffectiveness of benefits monetization program: it often proves to be not as beneficial as its predecessor.
According to a sociological study, every fifth citizen of the Russian Federation can not get necessary medications.
At least 20% of Russian citizens can not afford drugs they need because they are too expensive. The data comes from the research of the Institute for Social Analysis and Forecasting of the Russian Academy of Sciences. One of the reasons for this is a flaw of domestic medicines and the monetization of benefits.
Another 26% of respondents got into a similar situation once or twice in last 6 months.
“At the same time, even if the federal budget provides its part in full, insufficient funding from regional budgets leads to a shortage of medicines,” Izvestia writes.
The situation is aggravated by the fact that federal and regional authorities are both involved in the provision of medical care.
Professor of the Institute of Biology and Chemistry Andrei Teleshev also told Izvestia that Russian drugs currently occupy only about 30% of the Russian pharmaceutical market.